Compare Heron Therapeutics Inc (HRTX) vs iShares 10 20 Year Treasury Bond ETF (TLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs iShares 10 20 Year Treasury Bond ETF — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while iShares 10 20 Year Treasury Bond ETF trades at $96.86. Which is the better fit depends on your goals.
| HRTX | TLH | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Fixed Income |
52-Week High | $1.49 | $105.36 |
52-Week Low | $0.32 | $96.39 |
Enterprise Value | $168.21M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About iShares 10 20 Year Treasury Bond ETF
TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.
Read more on TLH →
